Clinical Trial Update: ImCardia for DHF to Treat Diastolic Heart Failure (DHF) Patient a Pilot Study [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 pilot study of ImCardia for diastolic heart failure (heart failure with preserved ejection fraction) was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• ImCardia

Snippet

Sponsor: CorAssist Cadiovascular Ltd. | Conditions: Heart Failure With Normal Ejection Fraction | EARLY_Phase 1 | Status: TERMINATED